Carrano Dominic Gabriel 4
4 · Veradermics, Inc · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Veradermics (MANE) CFO Dominic Carrano Receives Option Award
What Happened
Dominic Gabriel Carrano, Chief Financial Officer of Veradermics, Inc. (MANE), received a derivative award on 2026-02-03 covering 148,011 underlying shares. The award is reported at an acquisition price of $0.00 (total $0) and is recorded as a grant/award (transaction code A) on the Form 4. This is a time‑based option grant (not an open‑market purchase or sale).
Key Details
- Transaction date: 2026-02-03; Form 4 filed: 2026-02-05 (timely filing). Accession: 0001628280-26-005899.
- Instrument: derivative award reported as an option grant for 148,011 shares at $0.00. Reported value: $0.
- Vesting (footnote): 25% vests on Feb 3, 2027 (one year cliff), then the remainder vests in equal monthly installments over the next 36 months, subject to continued service.
- Shares owned following the transaction: not specified in the provided filing.
- No sale or cash exercise accompanied this grant; it is a compensation award.
Context
This filing documents a compensation-related option grant to the CFO. Such grants typically vest over time and do not represent an immediate purchase or sale of stock; they become economically meaningful only as they vest and, if applicable, are exercised. The footnote confirms the multi-year vesting schedule and the continued-service requirement.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-02-03+148,011→ 148,011 totalExercise: $17.00Exp: 2036-02-03→ Common Stock (148,011 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share, on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.